We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Freek Verheugt

Freek WA Verheugt MD, FESC, FACC, FAHA

Emeritus Professor of Cardiology at the Heart-Lung Centre of the University Medical Centre of Nijmegen, The Netherlands, Chairman of the Department of Cardiology, Onze Lieve Vrouwe Gasthuis (OLVG) in Amsterdam, The Netherlands

Professor Freek Verheugt is Emeritus Professor of Cardiology at the Heart-Lung Centre of the University Medical Centre of Nijmegen, The Netherlands, and was Chairman of the Department of Cardiology, Onze Lieve Vrouwe Gasthuis (OLVG) in Amsterdam, The Netherlands.

Prof. Verheugt graduated from the University of Amsterdam in 1974 and wrote a thesis on platelet and granulocyte antigens and antibodies. He trained in cardiology at the Thoraxcenter of the Erasmus Medical Centre, University in Rotterdam. He has been a Professor at the University of Colorado Health Sciences Center in Denver, CO, USA, and at the Free University in Amsterdam. He was President of the Netherlands Society of Cardiology between 1999 and 2001. Prof. Verheugt’s main fields of scientific interest are pharmacological and interventional treatments of acute coronary syndromes and atrial fibrillation.

Prof. Verheugt has published over 450 papers in peer-reviewed international journals including The New England Journal of Medicine, The Lancet, Circulation, Journal of the American College of Cardiology and European Heart Journal, of which he is an Editorial Board Member. He has over 23,000 citations, an H index of 62 and is also an editorial adviser of The Lancet, The New England Journal of Medicine and Circulation.